Dxcover Shares Performance Data on Brain Cancer Liquid Biopsy Test at ESMO Congress
Published . Updated .
This report does not map to a usual set of affected companies.
Directly affected
- No company is named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Dxcover Shares Performance Data on Brain Cancer Liquid Biopsy Test at ESMO Congress GenomeWeb
Source: GenomeWeb
This story
| Company | When | Move | Status |
|---|---|---|---|
| GLD | three days earlier | +3.41% | final price |
| GLD | five days earlier | +3.59% | final price |
| QQQ | three days earlier | +2.96% | final price |
| QQQ | five days earlier | +1.97% | final price |
| SPY | three days earlier | +1.68% | final price |
| SPY | five days earlier | +0.82% | final price |
| TLT | three days earlier | -1.30% | final price |
| TLT | five days earlier | -2.26% | final price |
This story
12 out of 100
“Dxcover Shares Performance Data on Brain Cancer Liquid Biopsy Test at ESMO Congress” scores 12 out of 100. The score uses 1 sources.